GLMD:NASDAQGalmed Pharmaceuticals Ltd. Analysis
Data as of 2026-08-08 - not real-time
$0.60
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $0.6019, Galmed Pharmaceuticals Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has gained 4.9% over the past 30 days. Relative strength is 56.0 — neutral — and the MACD signal is bullish. Watch $0.4570 as support and $0.6210 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 84.9%, a beta of 1.74 and a maximum drawdown of 70.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 84.9%, a beta of 1.74 and a maximum drawdown of 70.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.
Top Market Events
Barron's8dGalmed Pharmaceuticals Ltd.Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical...ADVFN22dGalmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline NASDAQ:GLMD Galmed...1dGalmed Pharmaceuticals Ltd.View Galmed Pharmaceuticals Ltd. GLMD stock quote prices, financial information, real-time...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.74
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.74
- 30-day volatility of 84.9%
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative return on equity of -72.1%
- Negative free cash flow
- 30-day volatility of 84.9%
Key Metrics & Analysis
Financial Health
P/E Ratio-0.6
ROE-72.12%
ROA-33.46%
P/B Ratio0.3
Op. Cash Flow$-7684000
Free Cash Flow$-4989625
Industry P/E29.5
Technical Analysis
TrendBearish
RSI56.0
Support$0.46
Resistance$0.62
MA 20$0.55
MA 50$0.58
MA 200$0.74
MACDBullish
VolumeDecreasing
Fear & Greed Index94.82
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.74
Volatility84.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.